Decreased cerebrospinal fluid levels of substance P in Machado-Joseph disease

Journal of the Neurological Sciences

Volumn 142, Issue 1-2, 1996, Pages 107-110

  Matsuishi, Toyojiro ^a   Sakai, Tetsuo ^b   Nagamitsu, Shinichiro ^a   Shoji, Hiroshi ^a   Ueda, Naoyuki ^a   Kaneko, Shinya ^a   Kano, Tatsuhiko ^a   Iwashita, Hiroshi ^b   Kato, Hirohisa ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Radiology Chikugo City Hospital   (Japan)

Author keywords

cerebrospinal fluid; Machado Joseph disease; substance P

Indexed keywords

SUBSTANCE P;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; HUMAN; MACHADO JOSEPH DISEASE; MALE; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0030271558     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(96)00159-1     Document Type: Article

References (13)

1. Cooper, P.E., M.H. Fernstrom, O.P. Rostad, S.E. Leeman and J.B. Martin (1981) The regional distribution of somatostatin, substance P and neurotensin in human brain. Brain Res., 218: 219-232.
2. Coutinho, P., A. Guimaraes and F. Scaravilli (1982) The pathology of Machado-Joseph disease: report of a possible homozygous case. Acta Neuropathol. (Berl), 58: 48-54.
3. Cramer, H., K. Rissler, N. Rosler, D. Strubel, D. Schaudt and F. Kuntzmann (1989) Immunoreactive substance P and somatostatin in the cerebrospinal fluid of senile parkinsonian patients. Eur. Neurol., 29: 1-5.
4. Kawaguchi, Y., T. Okamoto, M. Taniwaki et al., (1994) CAG expansions in a novel gene from Machado-Joseph disease at chromosome 14q32.1. Nature Genet., 8: 221-227.
5. Kitamura, J., Y. Kubuki, K. Tsuruta, T. Kurihara and S. Matsukura (1989) A new family with Joseph disease in Japan. Arch Neurol., 46: 425-428.
6. Mai, J.K., P.H. Stephens, A. Hope and A.C. Cuello (1986) Substance P in the human brain. Neuroscience, 17: 709-739.
7. Mroz, E.A., Brownstein, M.J., Leeman, S.E. (1976) Evidence for substance P in the striatonigral tract. Brain Res., 113: 597-599.
8. Nutt, J.G., E.A. Mroz, S.E. Leeman, A.C. Williams, W.K. Engel and T.N. Chase (1980) Substance P in human cerebrospinal fluid: reductions in peripheral neuropathy and autonomic dysfunction. Neurology, 30: 1280-1285.
9. Rimon, R., P. Le. Greves, F. Nyberg, L. Heikkila, L. Salmela and L. Terenius (1984) Elevation of substance P-like peptides in the CSF of psychiatric patients. Biol. Psychiatry, 19: 509-516.
10. Rosenberg, R.N., W.L. Nyhan, C. Bay and P. Shore (1976) Autosomal dominant striatonigral degeneration: a clinical, pathologic, and biochemical study of a new genetic disorder. Neurology, 26: 703-714.
11. Rosler, N., C. Reuner, J. Geiger, K. Rissler and H. Cramer (1990) Cerebrospinal fluid levels of immunoreactive substance P and somatostatin in patients with multiple sclerosis and inflammatory CNS disease. Peptides, 11: 181-183.
12. Sakai, T., and K. Oda (1993) Abundant reinnervation in peripheral nerves in Joseph disease. Neurology, 43: 428-430.
13. Sakai, T., M. Ohta and H. Ishino (1983) Joseph disease in a non-Portuguese family. Neurology, 33: 74-80.